Chargement en cours...
Enhancing the clinical coverage and anticancer efficacy of immune checkpoint blockade through manipulation of the gut microbiota
Although anticancer therapy with immune checkpoint blockers has seen unprecedented success, it fails to control neoplasia in most patients and often causes immune-related adverse events (irAEs). Our recent research shows the immunostimulatory and antitumor effects of CTLA-4 blockade depend on distin...
Enregistré dans:
| Publié dans: | Oncoimmunology |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Taylor & Francis
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5283646/ https://ncbi.nlm.nih.gov/pubmed/28197360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1132137 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|